ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 10, October 2026 | pp. 732–739
DOI: 10.46882/AJIDR/149009
Article Type: Research Article
Title: Molecular epidemiology and amphotericin B susceptibility of Histoplasma capsulatum in progressive disseminated histoplasmosis
Names of Authors: Mateo Silva¹*, Zainab Abubakar², Stefan Lindqvist³
Abstract: Progressive disseminated histoplasmosis is a life-threatening systemic endemic mycosis that frequently mimics disseminated tuberculosis in immunocompromised hosts. We determined fungal antigen sensitivity, internal transcribed spacer clades, and antifungal minimum inhibitory concentrations among patients with advanced immunosuppression. Urine, bone marrow, and blood specimens from 110 suspected cases were examined via Histoplasma galactomannan enzyme immunoassay and broth microdilution. Disseminated histoplasmosis was confirmed in 23.6 percent of patients, with liposomal amphotericin B and itraconazole showing uniform in vitro potency. Rapid urinary antigen screening reduces diagnostic delays and early mortality.
Keywords: Histoplasma capsulatum, Disseminated histoplasmosis, Endemic mycosis, Fungal antigen, Antifungal susceptibility
Citation: Silva M, Abubakar Z, Lindqvist S (2026). Molecular epidemiology and amphotericin B susceptibility of Histoplasma capsulatum in progressive disseminated histoplasmosis. African Journal of Infectious Diseases Research, 13(10): 732–739. DOI: 10.46882/AJIDR/149009
Manuscript Timeline: Received: August 22, 2026; Revised: September 20, 2026; Accepted: October 12, 2026; Published: October 19, 2026
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read